We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Brand firm Johnson & Johnson (J&J) says authorized generics are legal under FDA regulations and any move to keep them off the market until another generic firm’s 180-day exclusivity period expires would violate federal drug law.